Generative Optogenetics Proposers Workshop
ID: DARPA-SN-26-19Type: Special Notice
Overview

Buyer

DEPT OF DEFENSEDEFENSE ADVANCED RESEARCH PROJECTS AGENCY (DARPA)DEF ADVANCED RESEARCH PROJECTS AGCYARLINGTON, VA, 222032114, USA

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714)

PSC

NATIONAL DEFENSE R&D SERVICES; DEPARTMENT OF DEFENSE - MILITARY; APPLIED RESEARCH (AC12)
Timeline
    Description

    The Defense Advanced Research Projects Agency (DARPA) is hosting a Proposers Workshop for the Generative Optogenetics (GO) program, aimed at developing a molecular machine for massless genetic information transfer into living cells using optical signals. The workshop, scheduled for January 7, 2026, in the Greater DC area, will facilitate ideation, proposal refinement, and team formation in anticipation of a Program Solicitation expected in December 2025. Participants will have opportunities for lightning talks, poster sessions, and to submit teaming profiles, with advance registration required by December 29, 2025. For further inquiries, interested parties can contact Dr. Matthew J. Pava at GO@darpa.mil.

    Point(s) of Contact
    Dr. Matthew J. Pava
    GO@darpa.mil
    Files
    Title
    Posted
    DARPA's Special Notice DARPA-SN-26-19 announces a Proposers Workshop for the Generative Optogenetics (GO) program, aiming to develop a molecular machine for massless genetic information transfer into living cells via optical signals. The workshop, on January 7, 2026, in the Greater DC area, seeks to foster ideation, proposal refinement, and teaming for the anticipated Program Solicitation (PS) in December 2025. Advance registration by December 29, 2025, is mandatory and includes opportunities for lightning talks, poster sessions, and teaming profiles. The GO program features two research objectives: De Novo Synthesis (RO1), which is mandatory and focuses on developing the core nucleic acid compiler (NAC), and optional Error Mitigation (RO2) for high-fidelity synthesis. The program spans two phases over 42 months, with Phase 1 (12 months) for component refinement and Phase 2 (30 months) for integration and in-vivo demonstration, culminating in specific technical metrics. The program prohibits the use of embryonic stem cells and emphasizes leveraging existing knowledge and computational tools for protein engineering.
    The DARPA Proposers Day Lightning Profile Slide outlines requirements for proposals, encouraging team formation to address technical areas. Proposers must submit a single, unclassified PDF slide in landscape orientation, detailing their project overview, research capabilities, and teaming needs. The slide should include PI and institution names, existing team members, relevant experience, institutional assets, and a clear description of project goals, approaches, technical challenges, and unique metrics. It also requires outlining how the technology will transition and specifying any technical challenges for which collaborators are sought. The document emphasizes conciseness, clarity, and the exclusion of proprietary information, videos, or animations.
    This document outlines the requirements for a project proposal, likely for a federal grant or RFP, focusing on scientific and technological research. It requests a clear, jargon-free project overview detailing objectives, proposed approaches, technical challenges, and program phase structure. Proposers must describe their existing team, relevant experience, institutional assets, and identify areas where they seek collaborators. The proposal should also articulate the anticipated impact of the team's success, including potential applications, unique metrics and milestones, and plans for technology transition. Contact information is required. The guidance emphasizes conciseness, encourages team formation to address all technical areas, and specifies that submissions must be unclassified, non-proprietary, and in a standard file format. The core purpose is to solicit detailed proposals for research and development projects from collaborative teams.
    Lifecycle
    Title
    Type
    Special Notice
    Similar Opportunities
    Discover DSO Day (D3)
    Dept Of Defense
    The Defense Advanced Research Projects Agency (DARPA) is hosting a Discover DSO Day (D3) event aimed at familiarizing participants with the Defense Sciences Office's mission and funding opportunities. This in-person event will take place on January 13, 2026, in Orlando, FL, and is designed to facilitate discussions between attendees and DSO program managers, particularly targeting small businesses, academic institutions, and first-time government contractors. Registration is required and will close on January 2, 2026, or when capacity is reached, with a limit of 200 registrants and a participation fee of $125. Interested individuals can contact the BAA Coordinator at discoverdsoday@darpa.mil for further information.
    Microsystems Technology Office (MTO) Office-wide
    Dept Of Defense
    The Defense Advanced Research Projects Agency (DARPA) is seeking innovative research proposals through its Microsystems Technology Office (MTO) under Broad Agency Announcement (BAA) HR001124S0028. The focus is on revolutionary research ideas in microsystems technology that are not currently addressed by ongoing MTO programs, specifically targeting three thrust areas: Scientific Disruption (including photonic, quantum, and bio/organic circuits), Microsystems Manufacturing Ecosystem (emphasizing sustainable fabrication), and Dual Use by Design (promoting commercial viability for defense applications). This initiative is crucial for advancing U.S. technological superiority and national security through high-risk, high-reward research. Interested parties must submit abstracts by January 15, 2026, and full proposals by March 2, 2026, with further details available from the BAA Coordinator at HR001124S0028@darpa.mil.
    GENETIC MEDICINES AND INDIVIDUALIZED MANUFACTURING FOR EVERYONE (GIVE)
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the Advanced Research Projects Agency for Health (ARPA-H), is soliciting proposals for the Genetic Medicines and Individualized Manufacturing for Everyone (GIVE) program. This initiative aims to revolutionize the biomanufacturing of RNA-based genetic medicines by fostering innovations in automated RNA manufacturing and integrated quality control, ultimately enabling rapid, cost-effective, and localized production in non-GMP environments. Interested parties must submit solution summaries by December 19, 2025, with full proposals due by February 27, 2026, and are encouraged to participate in a Proposers’ Day on November 13, 2025, for further insights. For additional information, please refer to the program's website or contact the designated email address.
    Disruptioneering Program Announcement
    Dept Of Defense
    The Department of Defense, through the Defense Advanced Research Projects Agency (DARPA), is announcing the Disruptioneering Program, aimed at soliciting rapid, focused exploratory investments in innovative research leading to prototype demonstrations. This program will utilize "Disruption Opportunities" (DOs) to target specific technical domains critical to national security, allowing DARPA to initiate new investments for unclassified efforts within 120 days from idea inception. Proposals must respond to individual DOs announced on SAM.gov, with evaluations based on scientific merit, relevance, and price reasonableness, and awards anticipated to be made as Other Transactions (OTs) for prototype agreements. Interested parties can contact the BAA Coordinator at DARPA-PA-25-07@darpa.mil for further information, with funding contingent on proposal quality and availability.
    Biological Technologies
    Dept Of Defense
    The Defense Advanced Research Projects Agency (DARPA) is soliciting proposals for its Biological Technologies Office (BTO) under Broad Agency Announcement HR001126S0003, aimed at leveraging biological properties and processes to enhance the protection of U.S. warfighters. The BAA invites innovative research proposals that focus on various areas, including biological and chemical technologies for national security, AI/ML applications, combat casualty care, and environmental solutions, with a clear exclusion of evolutionary improvements to existing practices. Proposals will be evaluated based on scientific merit, relevance to DARPA's mission, and cost realism, with multiple award types anticipated, including contracts and cooperative agreements, and an accelerated award option available for proposals under $2 million. Interested parties should submit abstracts and proposals on a rolling basis until September 30, 2026, and can contact the BAA Coordinator at BTOBAA2026@darpa.mil for further information.
    TTO Office Wide (OW) BAA 2025
    Dept Of Defense
    The Department of Defense, through the Defense Advanced Research Projects Agency (DARPA), is soliciting innovative proposals under the Broad Agency Announcement (BAA) titled "TTO Office Wide (OW) BAA 2025." This initiative aims to enhance national security by fostering technological advancements in areas such as system design, manufacturing, and disruptive innovation, with a focus on improving military capabilities and operational effectiveness. Proposals should align with DARPA's mission to create revolutionary platforms and systems, and must adhere to specific submission guidelines, including a maximum of 25 pages for technical proposals and a two-page limit for executive summaries. Interested parties must submit their proposals by June 22, 2026, and can direct inquiries to the BAA Coordinator at HR001125S0011@darpa.mil.
    Quantum Benchmarking Initiative (QBI) 2026 Announcement
    Dept Of Defense
    The Defense Advanced Research Projects Agency (DARPA) is soliciting innovative proposals for the Quantum Benchmarking Initiative (QBI) 2026, aimed at developing utility-scale quantum computers by 2033. This initiative seeks to explore groundbreaking approaches to constructing fault-tolerant quantum computing systems and computational workflows, specifically excluding evolutionary improvements to existing technologies. The program anticipates multiple awards through specific QBI Topic (QBIT) calls, which will detail research areas, proposal processes, and deadlines, with a focus on high-risk, high-reward research. Interested parties should submit proposals in response to the defined QBIT calls and can contact the QBI PA Coordinator at QBI@darpa.mil for further information.
    DARPA's Commercial Solutions Opening (DCSO) for Commercial Strategy
    Dept Of Defense
    The Defense Advanced Research Projects Agency (DARPA) is soliciting proposals under its Commercial Solutions Opening (DCSO) for transitioning and commercializing innovative solutions derived from DARPA-funded research and development efforts. The primary objective is to close military and civilian capability gaps by leveraging commercial solutions, with a particular focus on the Embedded Entrepreneur Initiative (EEI), which funds entrepreneurs to assist in commercialization efforts. This initiative is crucial for enhancing national security and economic growth by bridging the gap between innovation and practical application. Proposals are due by April 30, 2026, and must adhere to the updated solicitation requirements, including a detailed Statement of Work and pricing documentation. Interested parties can contact Melissa Ramirez at DARPACSO@darpa.mil for further information.
    Generative Unconstrained Intelligence Drug Engineering (GUIDE) collaboration between U.S. interagency, academic and industry partners
    Dept Of Defense
    The Department of Defense, specifically the U.S. Army, is seeking collaboration with qualified entities for the Generative Unconstrained Intelligence Drug Engineering (GUIDE) program, aimed at accelerating the development of medical countermeasures for warfighters. This initiative involves an integrated computational and experimental platform that leverages advanced simulation and machine learning to enhance the discovery and design of biological products and small molecule drugs, ensuring safety, efficacy, and manufacturability. The GUIDE program is critical for improving preparedness against diverse threats and is executed under a Participant Basic Agreement (PBA), with interested parties encouraged to demonstrate their technical relevance by contacting the primary points of contact, Joseph McCaffery and Keith Pereira, via email. Participation is contingent upon registration in the System for Award Management (SAM) database, and the government emphasizes that this announcement is for planning purposes only, with no commitment to award contracts at this stage.
    Strategic Technology Office-wide Broad Agency Announcement
    Dept Of Defense
    The Defense Advanced Research Projects Agency (DARPA) is seeking innovative research proposals through its Strategic Technology Office-wide Broad Agency Announcement (BAA) HR001125S0001, which is open until December 19, 2025. The BAA aims to fund revolutionary advances in science, devices, or systems that enhance U.S. military and national security capabilities, specifically excluding evolutionary improvements to existing technologies. Proposals should address a wide range of topics, including artificial intelligence, autonomy, advanced computing, and communications, with the goal of developing disruptive technologies for future battlespaces. Interested parties can contact the BAA Coordinator at HR001125S0001@darpa.mil for further information and are encouraged to submit abstracts prior to full proposals to ensure alignment with DARPA's mission and avoid duplication of existing efforts.